Diseases of the endocrine and hematologic systems
Conditions
Interventions
AVS determined the classification of primary aldosteronism
Index test:18F-AIF-NOTE-Pentixafor PET/CT imaging,18F-AIF-NOTE-Pentixafor PET/MR imaging
Sponsors
The First Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Adult patients (aged 18 or above); 2.Adrenal tumors want to clarify the function or dominant side of the tumor; 3.Tumor patients who cannot be diagnosed or staged using 18F-FDG.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating patients; 2. Patients with ethanol allergy; 3. Patients with claustrophobia; 4. Patients who are unable to remain lying down and still for more than 15 minutes due to various reasons; 5. Study participants, parents or legal representatives who are unable or unwilling to provide written informed consent; 6. Patients whom the researcher deems unsuitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax;CT;MR; | — |
Secondary
| Measure | Time frame |
|---|---|
| SUVmean;sensitivity;specificity; | — |
Countries
China
Contacts
Public ContactLinhan Zhang
The First Affiliated Hospital of Harbin Medical University
Outcome results
None listed